Challenge
- Global rare-disease company operating in 30+ countries with an expansive R&D footprint
- Needed to review the operating model, footprint and resource model ahead of broader organizational changes, including anticipation of bolt-on acquisitions
- Streamlined operations and governance were important
Solution
- Assessed the “as-is” model through analysis of materials and stakeholder interviews
- Mapped structure, capabilities, processes and IT systems globally
- Identified and prioritised efficiency opportunities with R&D leadership
- Designed a future-state Target Operating Model across the same four areas (lean structure, enhanced capabilities, standardised processes, integrated IT) with a focus on maintaining a robust governance and compliance framework
- Mapped detailed organisation for implementation
Outcome
- Reduced operational complexity creating a leaner, more efficient R&D function with significant savings
- Standardised model ready to absorb future acquisitions
- Robust governance and regulatory alignment across R&D